Los Angeles Capital Management LLC Takes Position in Annexon, Inc. $ANNX

Los Angeles Capital Management LLC acquired a new stake in shares of Annexon, Inc. (NASDAQ:ANNX) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 20,196 shares of the company’s stock, valued at approximately $48,000.

A number of other institutional investors have also recently added to or reduced their stakes in ANNX. Bank of New York Mellon Corp boosted its stake in Annexon by 25.2% during the 1st quarter. Bank of New York Mellon Corp now owns 288,698 shares of the company’s stock valued at $557,000 after purchasing an additional 58,152 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Annexon in the 1st quarter worth $127,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Annexon by 164.1% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 34,026 shares of the company’s stock valued at $66,000 after buying an additional 21,143 shares during the period. XTX Topco Ltd boosted its stake in Annexon by 65.4% during the first quarter. XTX Topco Ltd now owns 58,130 shares of the company’s stock valued at $112,000 after buying an additional 22,979 shares in the last quarter. Finally, J. Safra Sarasin Holding AG boosted its stake in Annexon by 63.4% during the first quarter. J. Safra Sarasin Holding AG now owns 254,538 shares of the company’s stock valued at $491,000 after buying an additional 98,794 shares in the last quarter.

Analyst Upgrades and Downgrades

ANNX has been the topic of several research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Annexon in a research report on Wednesday, October 8th. HC Wainwright reiterated a “buy” rating and issued a $14.00 target price on shares of Annexon in a report on Friday, August 15th. Finally, Zacks Research upgraded shares of Annexon from a “strong sell” rating to a “hold” rating in a report on Monday, August 18th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $12.50.

Annexon Trading Up 6.0%

ANNX stock opened at $3.20 on Wednesday. Annexon, Inc. has a one year low of $1.28 and a one year high of $5.66. The firm has a 50-day moving average of $2.99 and a two-hundred day moving average of $2.54. The firm has a market capitalization of $382.83 million, a PE ratio of -2.48 and a beta of 1.28.

Annexon (NASDAQ:ANNX) last released its earnings results on Monday, November 10th. The company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.03). On average, equities research analysts anticipate that Annexon, Inc. will post -0.96 earnings per share for the current year.

About Annexon

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.